John Gay
Keine laufenden Positionen mehr
Vermögen: 47 $ am 31.03.2024
Profil
John M.
Gay worked as a Director of SEC Reporting at Valassis Digital Corp.
and Maxpoint, Inc. He was also a Controller at Furiex Pharmaceuticals, Inc. and an Audit Senior Manager at Deloitte & Touche LLP and Arthur Andersen LLP.
Currently, he is the Chief Financial & Accounting Officer & Secretary at NVN Liquidation, Inc. He also has a history with The University of North Carolina at Chapel Hill.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NVN LIQUIDATION INC
0,17% | 07.06.2023 | 46 831 ( 0,17% ) | 47 $ | 31.03.2024 |
Ehemalige bekannte Positionen von John Gay
| Unternehmen | Position | Ende |
|---|---|---|
| NVN LIQUIDATION, INC. | Finanzdirektor/CFO | 26.09.2023 |
| MAXPOINT INTERACTIVE INC | Corporate Officer/Principal | 01.04.2018 |
| FURIEX PHARMACEUTICALS INC | Comptroller/Controller/Auditor | 01.05.2014 |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.05.2010 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NVN LIQUIDATION, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Furiex Pharmaceuticals, Inc.
 Furiex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Furiex Pharmaceuticals, Inc. operates as a drug development collaboration company that uses innovative clinical development design to accelerate and increase value of drug development programs by advancing them through the drug discovery and development process in a cost-efficient manner. Its drug development programs are designed and driven by a core team with extensive drug development experience. Furiex Pharmaceuticals was founded in 1998 and is headquartered in Morrisville, NC. | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Commercial Services |
Valassis Digital Corp.
 Valassis Digital Corp. Miscellaneous Commercial ServicesCommercial Services Valassis Digital Corp. is a marketing technology company, which provides business intelligence and marketing automation software services. It delivers local, targeted digital marketing campaigns through various channels such as display, mobile, social, and video channels. The company was founded by Joseph W. Epperson, Gretchen Joyce, and Kurt Carlson in September 13, 2006 and is headquartered in Morrisville, NC. | Commercial Services |
